Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does a single MTHFR A1298C risk allele usually have only a modest effect on homocysteine metabolism?

A single MTHFR A1298C allele usually has a modest, variable functional effect and little independent impact on homocysteine metabolism.

PlausibleSeptember 16, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

A single MTHFR A1298C risk allele usually has a modest and variable effect on MTHFR function, and its clinical relevance to homocysteine metabolism is difficult to determine without homocysteine, folate, and vitamin B12 results.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says one A1298C risk allele can slightly reduce MTHFR function, but the effect is usually limited and inconsistent. It frames the clinical meaning as dependent on actual homocysteine, folate, and vitamin B12 results rather than genotype alone. The mechanism described is reduced MTHFR support for 5-methyltetrahydrofolate production and homocysteine remethylation, with nutritional status often being more important than the variant itself.

Verified conclusion

A1298C (rs1801131) is a common MTHFR polymorphism. For a 71-year-old man with one C allele (AC), the result indicates at most a modest biochemical predisposition, not a diagnosis of impaired methylation, folate deficiency, or hyperhomocysteinemia.

Functional and clinical evidence

  • Human lymphocyte/enzyme data estimate MTHFR activity at approximately 83% of wild type in AC heterozygotes, versus about 61% in CC homozygotes. Thus, one allele has a measurable but limited and assay-dependent functional effect.
  • This modest activity reduction generally does not produce a meaningful increase in plasma homocysteine or substantial changes in plasma/red-cell folate in isolated AC carriers, particularly with adequate folate and vitamin B12 status.
  • A1298C is milder than C677T. Findings from combined A1298C/C677T genotypes should not be assumed to apply to isolated AC status.

Mechanistic context

  • MTHFR converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-methyl-THF).
  • 5-methyl-THF supplies the methyl group for remethylation of homocysteine to methionine. Nevertheless, the partial activity reduction associated with one A1298C allele usually does not create a detectable homocysteine phenotype.
  • Measured nutritional status is more influential: plasma total homocysteine is inversely associated with vitamin B12 and folate status.

Practical interpretation

  • Fasting total homocysteine establishes whether the relevant biochemical abnormality is present; folate and vitamin B12 identify common reversible contributors. If B12 status is uncertain or homocysteine remains unexplained, methylmalonic acid and evaluation for other acquired or metabolic causes may be appropriate.
  • Genotype should not be used to infer folate/B12 deficiency or to change standard folic-acid recommendations.

Bottom line

  • A single A1298C allele usually has modest, variable functional impact and little independent clinical effect on homocysteine. Its relevance cannot be determined from genotype alone; homocysteine, folate, and B12 results are the clinically informative data.

References

  1. The Implication of a Polymorphism in the ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. MTHFR Gene Explained: C677T and A1298C Variants, ... — geneticlifehacks.com ↗
  3. MTHFR A1298C Explained: How It Differs from C677T | Genova Lab — genova.health ↗
  4. MTHFR A1298C (rs1801131) — GeneOps — geneops.ai ↗
  5. Methylenetetrahydrofolate reductase and psychiatric diseases - Translational Psychiatry — nature.com ↗
  6. Methylenetetrahydrofolate Reductase Deficiency - NCBI - NIH — ncbi.nlm.nih.gov ↗
  7. A1298C methylenetetrahydrofolate reductase mutation and coronary ... — pubmed.ncbi.nlm.nih.gov ↗
  8. Vitamin B-12 status is inversely associated with plasma ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→